Clever Leaves Holdings Inc. (CLVR) vs Lifecore Biomedical, Inc. (LFCR)

Clever Leaves Holdings Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $162.4M against $96.5M — 1.7× the size. Clever Leaves Holdings Inc. grew revenue faster over the last twelve months: 6.14% against −10.0%. Lifecore Biomedical, Inc. has the higher net margin (−37.5% vs −102.8%) and the higher return on invested capital (−2.80% vs −52.6%). Across the 15 metrics below, Lifecore Biomedical, Inc. leads on 8 and Clever Leaves Holdings Inc. on 7.

Valuation

Metric CLVR LFCR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 1.32 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 0.45 n/m 12.29
EV/Sales (0.33) 2.73 2.56
Earnings yield 0.00% (23.10%) (2.99%)
Free cash flow yield 0.00% (3.21%) 0.00%

Profitability

Metric CLVR LFCR Drug Manufacturers Specialty & Generic median
Gross margin 37.64% 26.86% 53.94%
Operating margin (89.53%) (6.89%) 0.00%
Net margin (102.77%) (37.54%) 0.00%
Free cash flow margin (49.82%) (4.24%) 0.00%
Return on equity (55.39%) 201.15% (0.40%)
Return on assets (42.95%) (19.32%) (3.32%)
Return on invested capital (52.59%) (2.80%) 0.00%

Growth

Metric CLVR LFCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 6.14% (10.03%) 10.01%
EPS growth (last fiscal year) 77.89% (439.33%) —
Revenue growth, 5-year CAGR — (4.24%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLVR LFCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 11.50 0.05
Current ratio 2.40 3.87 2.31
Net debt to EBITDA 0.45 (15.59) 0.85

Dividend

Metric CLVR LFCR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CLVR LFCR Drug Manufacturers Specialty & Generic median
Market cap 96.49m 162.39m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack